How Many Doses Are in a Mounjaro Pen? A Comprehensive Guide

Last reviewed: July 14, 2026

Last updated: July 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, the active ingredient in Mounjaro and Zepbound, comes in pre-filled pens that deliver weekly subcutaneous injections over a 4-week cycle. Each pen holds enough medication for one month of treatment following a standardized titration schedule. Understanding pen capacity and dose progression helps you manage expectations and plan your weight loss journey effectively.

Understanding Tirzepatide Pen Capacity and Weekly Dosing

A standard tirzepatide pen is designed to deliver one weekly injection for four consecutive weeks, meaning each pen contains four separate doses. The pen uses an automated injection mechanism that measures and dispenses the exact amount of medication needed for each week. This design eliminates the need for manual syringes or vials, making self-administration straightforward for patients managing their treatment at home.

The four-week supply system aligns with the medication's weekly dosing schedule, which differs significantly from daily injection therapies. Each weekly dose allows the tirzepatide compound to reach steady-state levels in your bloodstream, supporting consistent appetite suppression and metabolic benefits. This weekly frequency offers better adherence compared to daily medications, as patients only need to remember one injection per week rather than daily oral or injectable medications.

Tirzepatide Dose Escalation: From Starting Dose to Maintenance

Tirzepatide therapy begins at a low starting dose designed to minimize gastrointestinal side effects while your body adapts to GLP-1 and GIP receptor activation. The standard initiation protocol calls for a 2.5 mg weekly dose during the first four weeks, with planned increases every 4 weeks until reaching your target maintenance dose. Most patients progress through doses of 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg based on individual tolerance and weight loss response.

Your prescriber determines the pace of dose escalation by monitoring your progress, side effect profile, and metabolic response. Some patients reach their optimal dose within 8-12 weeks, while others benefit from remaining at intermediate doses longer. PlexusDx's approach emphasizes gradual titration to maximize tolerability and long-term adherence, ensuring your body has adequate time to adjust to each new dose level before advancing further.

How PlexusDx Compounded Tirzepatide Differs from Brand Pens

PlexusDx compounds tirzepatide through licensed 503A compounding pharmacies, offering the same active pharmaceutical ingredient as brand medications but at significantly lower cost. Compounded formulations are dispensed in patient-friendly vials or syringes rather than pre-filled pens, giving your provider flexibility to adjust doses between appointments. This customization allows for smaller incremental changes if you experience side effects or require a dose reduction for any reason.

The compounded approach eliminates the constraint of fixed-dose pens, which typically come in standardized strengths. PlexusDx's tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with a flat pricing model—your dose may need to go up, but your price won't. This transparent, non-tiered pricing removes financial barriers to reaching your optimal therapeutic dose, whether that's 2.5 mg or 15 mg weekly.

Maximizing Your Tirzepatide Treatment with Genetic Personalization

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic peptide profile allows PlexusDx providers to personalize your starting dose, escalation timeline, and choice of compound. Patients with certain GLP1R variants may achieve rapid weight loss at lower doses, while others with FTO or MC4R variants might require higher therapeutic doses for meaningful results. The Precision Peptide Genetic Test ($99 add-on after your first month) transforms tirzepatide therapy from a one-size-fits-all approach into a truly personalized treatment plan aligned with your unique biology.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many injections are in one tirzepatide pen?

A standard tirzepatide pen contains four weekly doses, one for each week of the month. Each week you use the pen once, and after four weeks, you begin a new pen with your next escalated dose or maintenance dose as prescribed.

Why does tirzepatide require weekly doses instead of daily injections?

Tirzepatide's long half-life allows it to remain effective in your system for a full week, making weekly dosing sufficient for appetite suppression and metabolic benefits. This weekly schedule improves medication adherence compared to daily therapies, as patients only need to remember one injection per week rather than daily dosing.

Will my tirzepatide dose increase cost more with PlexusDx?

No. PlexusDx's compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with flat pricing across all dose levels. Your dose may need to go up during titration, but your monthly price remains the same regardless of whether you're at 2.5 mg or 15 mg weekly.

What are the most common side effects during tirzepatide dose escalation?

Nausea, vomiting, and diarrhea are the most frequently reported side effects, particularly during the first 2-4 weeks after each dose increase. These gastrointestinal effects typically resolve within days to weeks as your body adapts. Gradual dose escalation through PlexusDx's approach helps minimize these effects and improves long-term treatment tolerance.

How does the Precision Peptide Genetic Test help with tirzepatide dosing?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro Doses
• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.